AT Fung, SE Reid, MP Jones, PR Healey, PJ … - British Medical Journal, 2007 - bjo.bmj.com Results: 15 publications reporting on 14 trials (1784 participants) were
included for meta-analysis. IOP reduction favoured latanoprost (weighted mean
difference (WMD) = 1.10 mm Hg (95% confidence interval (CI) 0.57 to 1.63)). ... Cited by 5 - Related articles - BL Direct - All 5 versions
O Eyawo, J Nachega, P Lefebvre, D Meyer, B …, 2009 - pubmedcentral.nih.gov A meta-analysis was conducted of head-to-head randomized trials of prostaglandin
therapies. We included randomized trials assessing head-to-head evaluations of
prostaglandin analogues travoprost, latanoprost and bimatoprost in patients ... Related articles - All 5 versions
A Worley, K Grimmer-Somers - Primary Health Care Research and Development, 2009 - Cambridge Univ Press Aim: This paper reports on a recent review of the prevalence of glaucoma, and
identifies factors that impact on its variable reporting. Background: Glaucoma
is a recognized chronic degenerative health problem worldwide, in which ... Related articles
MA MOUSSALLI, NM VALENCIA, C TAPIA - oftalmologos.org.ar Concepto y definición El glaucoma de baja presión (GBP) es una entidad que se
presta muchas veces a una duda diagnóstica, lo cual dificulta brindarle al pa-
ciente una correcta definición de su patología, pronóstico y adecuado ... Related articles - View as HTML
A Russo, I Riva, T Pizzolante, F Noto, L …, 2008 - pubmedcentral.nih.gov Latanoprost is a prostaglandin F2-alpha isopropyl ester prodrug which is rapidly
hydrolyzed by esterases in the cornea to the biologically active latanoprost
acid. When latanoprost is topically administered into the eye, the cornea ... Related articles - All 5 versions
CG Owen, IM Carey, S de Wilde, PH Whincup … - Eye, 2008 - nature.com Percentage persistent at 1-year rose after 1997 when prostaglandins were
introduced; from 61% in 1994–1996 to 70% in 2002–2004. Persistence with any
treatment did not differ between those initiated on -blockers compared to ... Cited by 1 - Related articles - All 2 versions
TK Mundorf, R Noecker, M Earl - Investigative Ophtalmology and Visual Science, 2004 - ARVO Results: There were no significant differences in baseline mean IOP (P=.146).
Bimatoprost provided lower mean IOP than travoprost at the month 2 and 3 study
visits. After 2 months of study medication, the mean IOP in the bimatoprost ... Cited by 1 - Related articles
DM Kim, JH Seo, SH Kim, SS Hwang - Journal of glaucoma, 2007 - journals.lww.com Skip Navigation Links Home > May 2007 - Volume 16 - Issue 3 > Comparison of
Localized Retinal Nerve Fiber Layer Defects Be... ... Supported by Grant No.
06-2005-218-0 from the Seoul National University Hospital Research Fund. Cited by 1 - Related articles - BL Direct - All 3 versions
